AI-ACCELERATED DRUG DISCOVERY

Focused On-demand Library for Prestin

Available from Reaxense
Predicted by Alphafold

Focused On-demand Libraries - Reaxense Collaboration

Explore the Potential with AI-Driven Innovation

This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.

We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.

Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.

Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.

 Fig. 1. The sreening workflow of Receptor.AI

The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.

Key features that set our library apart include:

  • The Receptor.AI platform integrates extensive information about the target protein, such as historical experiments, academic research, known ligands, and structural insights, thereby increasing the likelihood of identifying highly relevant compounds.
  • The platform’s sophisticated molecular simulations are designed to discover potential binding sites, ensuring that our focused library is optimal for the discovery of allosteric inhibitors and binders for cryptic pockets.
  • With over 50 customisable AI models, verified through extensive testing in commercial drug discovery and research, Receptor.AI is efficient, reliable, and precise. These models are essential in the production of our focused libraries.
  • Receptor.AI not only produces focused libraries but also provides full services and solutions at every stage of preclinical drug discovery, with a success-based pricing structure that aligns our interests with the success of your project.

partner

Reaxense

upacc

P58743

UPID:

S26A5_HUMAN

Alternative names:

Solute carrier family 26 member 5

Alternative UPACC:

P58743; Q496J2; Q7Z7F3; Q86UF8; Q86UF9; Q86UG0

Background:

Prestin, identified as Solute carrier family 26 member 5, is a pivotal voltage-sensitive motor protein in the outer hair cells (OHC) of the ear, driving electromotility essential for sound amplification. It operates by converting transmembrane electric potential changes into mechanical displacements, crucial for hearing. Prestin's function involves a complex mechanism where it may act as an incomplete transporter, with chloride ions or charged amino acid residues serving as voltage sensors, facilitating its unique electromotility capabilities.

Therapeutic significance:

Prestin's malfunction is linked to Deafness, autosomal recessive, 61, a form of sensorineural hearing loss. Understanding Prestin's role could open doors to potential therapeutic strategies, offering hope for treating hearing impairments.

Looking for more information on this library or underlying technology? Fill out the form below and we'll be in touch with all the details you need.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.